[1]
Yang, R.; Chen, J.B.; Xiao, C.F.; Liu, Z.C.; Gao, Z.Y.; Yan, S.J.; Zhang, J.H.; Zhang, H.B.; Lin, J. Inclusion complex of GA-13316 with β-cyclodextrin: preparation, characterization, molecular modeling, and in vitro evaluation. Carbohydr. Polym., 2014, 111, 655.
[2]
Efiana, N.A.; Phan, T.N.Q.; Wicaksono, A.J.; Bernkop-Schnurch, A. Mucus permeating self-emulsifying drug delivery systems (SEDDS): About the impact of mucolytic enzymes. Colloids Surf. B Biointerfaces, 2017, 161, 228-235.
[3]
Chaudhury, A.; Das, S. Folate receptor targeted liposomes encapsulating anti-cancer drugs. Curr. Pharm. Biotechnol., 2015, 16(4), 333-343.
[4]
Deng, H.; Liu, J.; Zhao, X.; Zhang, Y.; Liu, J.; Xu, S.; Deng, L.; Dong, A.; Zhang, J. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. Biomacromolecules, 2014, 15(11), 4281-4292.
[5]
Zhang, T.; Luo, J.; Fu, Y.; Li, H.; Ding, R.; Gong, T.; Zhang, Z. Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer. Colloids Surf. B Biointerfaces, 2016, 150, 89-97.
[6]
Dousa, M.; Meca, L.; Gibala, P.; Jirman, J.; Tkadlecova, M.; Srbek, J.; Salandova, J.; Kovalcikova, E.; Brichac, J. Esterification of ibuprofen in soft gelatin capsules formulations-identification, synthesis and liquid chromatography separation of the degradation products. J. Chromatogr. Sci., 2017, 55(8), 790-797.
[7]
Stephenson, G.A.; Aburub, A.; Woods, T.A. Physical stability of salts of weak bases in the solid-state. J. Pharm. Sci., 2011, 100(5), 1607-1617.
[8]
Schultheiss, N.; Newman, A. Pharmaceutical cocrystals and their physicochemical properties. Cryst. Growth Des., 2009, 9(6), 2950-2967.
[9]
Serajuddin, A.T.M. Salt formation to improve drug solubility. Adv. Drug Deliv. Rev., 2007, 59(7), 603-616.
[10]
Zhao, B.; Gu, S.; Du, Y.; Shen, M.; Liu, X.; Shen, Y. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. Int. J. Pharm., 2017, 535(1-2), 164-171.
[11]
Edwards, F.; Tsakmaka, C.; Mohr, S.; Fielden, P.R.; Goddard, N.J.; Booth, J.; Tam, K.Y. Using droplet-based microfluidic technology to study the precipitation of a poorly water-soluble weakly basic drug upon a pH-shift. The Analyst , 2013, 138(1), 339-345.
[12]
Pu, X.H.; Sun, J.; Li, M.; He, Z.G. Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs. Curr. Nanosci., 2009, 5(4), 417-427.
[13]
Bergstrom, C.A.; Wassvik, C.M.; Johansson, K.; Hubatsch, I. Poorly soluble marketed drugs display solvation limited solubility. J. Med. Chem., 2007, 50(23), 5858-5862.
[14]
Shah, S.M.; Ullah, F.; Khan, S.; Shah, S.M.; de Matas, M.; Hussain, Z.; Minhas, M.U. AbdEl-Salam, N.M.; Assi, K.H.; Isreb, M. Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation. Drug Des. Devel. Ther., 2016, 10, 3837-3850.
[15]
Liu, C.Z.; Chang, J.H.; Zhang, L.; Xue, H.F.; Liu, X.G.; Liu, P.; Fu, Q. Preparation and evaluation of diosgenin nanocrystals to improve oral bioavailability. AAPS PharmSciTech, 2016, 1-10.
[16]
Kassem, M.A.; ElMeshad, A.N.; Fares, A.R. Enhanced solubility and dissolution rate of lacidipine nanosuspension: formulation via antisolvent sonoprecipitation technique and optimization using box-behnken design. AAPS PharmSciTech, 2016, 1-14.
[17]
Rabinow, B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov., 2004, 3(9), 785-796.
[18]
Pu, X.; Sun, J.; Wang, Y.; Wang, Y.; Liu, X.; Zhang, P.; Tang, X.; Pan, W.; Han, J.; He, Z. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Int. J. Pharm., 2009, 379(1), 167-173.
[19]
Moschwitzer, J.; Achleitner, G.; Pomper, H.; Muller, R.H. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur. J. Pharm. Biopharm., 2004, 58(3), 615-619.
[20]
Gao, L.; Liu, G.; Wang, X.; Liu, F.; Xu, Y.; Ma, J. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Int. J. Pharm., 2011, 404(1-2), 231-237.
[21]
Bi, C.; Miao, X.Q.; Chow, S.F.; Wu, W.J.; Yan, R.; Liao, Y.H.; Chow, A.H.; Zheng, Y. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution. Nanotechnol. Biol. Med., 2017, 13(3), 943-953.
[22]
Müller, R.H.; Peters, K.; Becker, R.; Kruss, B. Nanosuspensions, A novel formulation for the i.v. administration of poorly soluble drugs.In; APGI, 1995, pp. 491-492.
[23]
Kumar, M.P.; Rao, Y.M.; Apte, S. Formulation of nanosuspensions of albendazole for oral administration. Curr. Nanosci., 2008, 4(1), 53-58.
[24]
Peters, K.; Leitzke, S.; Diederichs, J.E.; Borner, K.; Hahn, H.; Muller, R.H.; Ehlers, S. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J. Antimicrob. Chemother., 2000, 45(1), 77-83.
[25]
Pu, X.H.; Sun, J.; Qin, Y.M.; Zhang, X.; Zhang, P.; Yan, Z.T.; He, Z.G. The passive targeting and the cytotoxicity of intravenous 10-HCPT nanosuspension. Curr. Nanosci., 2012, 8(5), 762-766.
[26]
Boistelle, R.; Astier, J.P. Crystallization mechanisms in solution. J. Cryst. Growth, 1988, 90(1-3), 14-30.
[27]
Florence, A.T.; Attwood, D. Physicochemical principles of pharmacy. Am. J. Pharm. Educ., 1998, 70(5), 122.
[28]
Liu, P.; Rong, X.; Laru, J.; van Veen, B.; Kiesvaara, J.; Hirvonen, J.; Laaksonen, T.; Peltonen, L. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int. J. Pharm., 2011, 411(1-2), 215-222.
[29]
Merisko-Liversidge, E.; Liversidge, G.G. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv. Drug Deliv. Rev., 2011, 63(6), 427-440.
[30]
Zhao, D.; Zhang, H.; Yang, S.; He, W.; Luan, Y. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance. Int. J. Pharm., 2016, 515(1-2), 281-292.
[31]
Gao, L.; Liu, G.; Kang, J.; Niu, M.; Wang, Z.; Wang, H.; Ma, J.; Wang, X. Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies. Colloids Surf. B Biointerfaces, 2013, 111, 277-281.
[32]
Malingre, M.M.; Terwogt, J.M.; Beijnen, J.H.; Rosing, H.; Koopman, F.J.; van Tellingen, O.; Duchin, K.; Huinink, W.W.; Swart, M.; Lieverst, J.; Schellens, J.H. Phase I and pharmacokinetic study of oral paclitaxel. J. Clin. Oncol., 2000, 18(12), 2468-2475.
[33]
Huizing, M.T.; Misser, V.H.S.; Pieters, R.C.; ten Bokkel Huinink, W.W.; Veenhof, C.H.N.; Vermorken, J.B.; Pinedo, H.M.; Beijnen, J.H. Taxanes: A new class of antitumor agents. Cancer Invest., 1995, 13(4), 381-404.
[34]
Lee, J.; Lee, S.J.; Choi, J.Y.; Yoo, J.Y.; Ahn, C.H. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur. J. Pharm. Sci., 2005, 24(5), 441-449.
[35]
Hong, J.; Li, Y.; Xiao, Y.; Li, Y.; Guo, Y.; Kuang, H.; Wang, X. Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy. Colloids Surf. B Biointerfaces, 2016, 145, 319-327.
[36]
Wang, Y.; Zheng, Y.; Zhang, L.; Wang, Q.; Zhang, D. Stability of nanosuspensions in drug delivery. J. Control. Release, 2013, 172(3), 1126-1141.
[37]
Ghosh, I.; Bose, S.; Vippagunta, R.; Harmon, F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int. J. Pharm., 2011, 409(1-2), 260-268.
[38]
Lauro, M.R.; Carbone, C.; Sansone, F.; Ruozi, B.; Chillemi, R.; Sciuto, S.; Aquino, R.P.; Puglisi, G. Innovative oral spray-dried Idebenone systems to improve patient compliance. Drug Development and Industrial Pharmacy,, 2016, 42(7), 1127-1136.
[39]
Kumar, G.; Sharma, S.; Shafiq, N.; Pandhi, P.; Khuller, G.K.; Malhotra, S. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis. Drug Deliv., 2011, 18(1), 65-73.
[40]
Ghosh, I.; Schenck, D.; Bose, S.; Ruegger, C. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: Effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. Eur. J. Pharm. Sci., 2012, 47(4), 718-728.
[41]
Mirshafiee, V.; Kim, R.; Park, S.; Mahmoudi, M.; Kraft, M.L. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. Biomaterials, 2016, 75, 295-304.
[42]
Kari, O.K.; Rojalin, T.; Salmaso, S.; Barattin, M.; Jarva, H.; Meri, S.; Yliperttula, M.; Viitala, T.; Urtti, A. Multi-parametric surface plasmon resonance platform for studying liposome-serum interactions and protein corona formation. Drug Deliv. Transl. Res., 2016, 7(2), 228-240.
[43]
Caracciolo, G.; Palchetti, S.; Colapicchioni, V.; Digiacomo, L.; Pozzi, D.; Capriotti, A.L.; La Barbera, G.; Lagana, A. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells. Langmuir, 2015, 31(39), 10764-10773.
[44]
Manjunath, K.; Venkateswarlu, V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Drug Target., 2006, 14(9), 632-645.
[45]
Wang, Y.; Li, X.; Wang, L.; Xu, Y.; Cheng, X.; Wei, P. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery. Int. J. Nanomed, 2011, 6, 1497-1507.
[46]
Wei, L.; Ji, Y.; Gong, W.; Kang, Z.; Meng, M.; Zheng, A.; Zhang, X.; Sun, J. Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals. Drug Dev. Ind. Pharm., 2015, 41(8), 1343-1352.
[47]
Yin, T.; Cai, H.; Liu, J.; Cui, B.; Wang, L.; Yin, L.; Zhou, J.; Huo, M. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel. Eur. J. Pharm. Sci., 2016, 83, 79-87.
[48]
Gao, W.; Chen, Y.; Thompson, D.H.; Park, K.; Li, T. Impact of surfactant treatment of paclitaxel nanocrystals on biodistribution and tumor accumulation in tumor-bearing mice. J. Control. Release, 2016, 237, 168-176.
[49]
Chen, Y.; Li, T. Cellular uptake mechanism of paclitaxel nanocrystals determined by confocal imaging and kinetic measurement. AAPS J., 2015, 17(5), 1126-1134.
42
2